News
FDA’s New Priority Voucher Program for Drug Developers Ties Incentives to Defined National Interests
The US Food and Drug Administration recently announced the launch of a regulatory incentive program pilot program, the ...
The FDA has agreed to fast-track its review of gepotidacin, an oral antibiotic already approved for urinary tract infections, ...
The U.S. Food and Drug Administration has approved Insmed's oral drug for a type of lung disease, the company said on Tuesday ...
The US Food and Drug Administration (FDA) recently announced the availability of the first-ever centralized database of Complete Response ...
U.S. FDA Accepts New Drug Application for Merck’s DOR/ISL Once-Daily Two-Drug Regimen for Treatment of Adults with Virologically Suppressed HIV-1.
Asianet Newsable on MSN58m
Insmed Stock Closes At Nearly 25-Year High As Analysts Get Bullish On FDA Nod For Lung Disease Drug: Retail Traders Ecstatic
Insmed shares surged after U.S. regulators approved Brinsupri, the first treatment for non-cystic fibrosis bronchiectasis.
After a decade of development, a Kansas City-based pharmaceutical company is on the brink of submitting its ADHD medication ...
AbbVie is seeking a new way to fight chronic lymphocytic leukemia by combining its oncology drug Venclexta with another ...
Achieve Life Sciences, Inc. has submitted a New Drug Application (NDA) to the U.S. FDA for cytisinicline, which, if approved, would be the first new pharmacotherapy for nicotine dependence in 20 ...
SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the ...
Potential NIH and FDA cuts could lower the number of new drugs that come to market in the next three decades, according to a ...
Johnson & Johnson (NYSE:JNJ) is one of the best trade‑war resistant stocks to buy now. On July 21, 2025, J&J submitted a New ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback